2002
DOI: 10.1097/00006324-200212001-00307
|View full text |Cite
|
Sign up to set email alerts
|

Joslin Vision Network Examination for Diabetic Retinopathy in a Veterans Hospital - Phase 2.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…The rate of laser therapy increased from 19.6 per 1000 patients with DM in 1999 to 29.5 per 1000 in 2003 for a 51% increase in the laser treatment rate. 18 In a retrospective observational cohort study, 19 …”
Section: Jvn Clinical Programsmentioning
confidence: 99%
See 1 more Smart Citation
“…The rate of laser therapy increased from 19.6 per 1000 patients with DM in 1999 to 29.5 per 1000 in 2003 for a 51% increase in the laser treatment rate. 18 In a retrospective observational cohort study, 19 …”
Section: Jvn Clinical Programsmentioning
confidence: 99%
“…A total of 679 (55.7%) had no DR in either eye, and 229 (18.8%) had mild NPDR in the more severe eye. Of the 908 patients with either no DR or mild NPDR in the eye with the more severe disease (74.5%), 533 (58.7%) had at least 1 non-DM ocular finding necessitating referral 19. …”
mentioning
confidence: 99%
“…9 Teleophthalmology, which involves telemedicine applied to clinical ophthalmology, is already in widespread use for nonemergency eye care. It is well established to screen for diabetic retinopathy [10][11][12][13] and retinopathy of prematurity. [14][15][16] The concept of Internetbased counseling of ophthalmology patients located remotely has existed for more than a decade, 17 and its use for urgent consultations has been described internationally, especially in Australia.…”
mentioning
confidence: 99%
“…The Joslin Vision Network (JVN) is a teleophthalmology modality developed by the Joslin Diabetes Center that has been validated as equal to or better than a live, dilated retinal examination for diagnosing the level of DR and diabetic macular edema (DME) [26,27] and is also able to identify other common non-DR eye diseases [28]. This technology does not use pupil dilation and is noninvasive, so it can be implemented in a primary care setting and easily integrated into the normal clinical workflow of care for patients with diabetes.…”
Section: Teleophthalmology: Preventing Blindness In Diabetic Patientsmentioning
confidence: 99%